Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iodine atoms, incorporated into contrast agents, are used to enhance radiographic images. Due to iodine's high atomic number (Z=53), it strongly absorbs X-rays, particularly at its k-edge (33.2 keV), through the photoelectric effect. This increased absorption leads to greater attenuation of X-rays in areas where the contrast agent is present, thereby enhancing contrast between different tissues or structures on radiographic images, especially in CT and angiography. The iodine is delivered via organic molecules like iohexol, iodixanol and ioversol. Safety considerations include potential allergic reactions and risks associated with renal function.
Enhanced photoelectric absorption of X-rays at the iodine k-edge (~33.2 keV), leading to increased local X-ray attenuation and improved contrast in radiographic images.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iodine Atoms (in Iodinated Contrast Agents).